Hematocrit battle puts patients on the losing end.
Neumann
M E
ME
D003363:Cost Control; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000628:therapy; D012051:Reimbursement Mechanisms / Q000191:economics*; D006435:Renal Dialysis
D004921:Erythropoietin